MedTrace Logo

Gustave Roussy Cancer Profiling

NCT04932525 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20000

Last updated 2026-02-06

No results posted yet for this study

Summary

The objective of STING study is to perform high throughput molecular analysis (next generation sequencing +/- immunological profiling) to estimate the proportion of patients with cancer presenting at least one targetable genomic alteration.

Conditions

  • Solid Tumor, Unspecified, Adult

Interventions

PROCEDURE

Biopsy

Blood and tumor samples for Genetic Profiling research

Sponsors & Collaborators

  • Gustave Roussy, Cancer Campus, Grand Paris

    lead OTHER

Principal Investigators

  • Antoine Italiano, MD PhD · Gustave Roussy, Cancer Campus, Grand Paris

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-10
Primary Completion
2033-05-10
Completion
2033-05-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04932525 on ClinicalTrials.gov